Latest News about IWINF
Recent news which mentions IWINF
Irwin Naturals Sued By East West Bank Over $40M Loan Default
August 13, 2024
From Benzinga
Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
December 05, 2023
From Benzinga
Irwin Naturals' Bold Leap: Cannabis, Psychedelics Drive Q3 Buzz Despite Falling Revenue & Surging Losses
November 28, 2023
Tickers
IWINF
From Benzinga
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
September 05, 2023
From Benzinga
Irwin Naturals Revenue Sluggish In Q2, Net Loss Grows YOY
August 28, 2023
Tickers
IWINF
From Benzinga
Cannabis Stock Gainers And Losers From August 25, 2023
August 25, 2023
From Benzinga
From Benzinga
Marijuana Stock Movers For August 15, 2023
August 15, 2023
From Benzinga
Cannabis Stock Movers For August 10, 2023
August 10, 2023
From Benzinga
Cannabis Stock Movers For July 27, 2023
July 27, 2023
From Benzinga
From Benzinga
Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More
May 08, 2023
From Benzinga
Cannabis Scandal And Resignation Of Oregon Official, USCC's New Leadership & More Executive Moves
May 05, 2023
From Benzinga
Psychedelics Company Confirms Shares Spinout, Another Fails To File Financials & Gets CTO Issue
May 03, 2023
Tickers
IWINF
From Benzinga
From Benzinga
From Benzinga
Irwin Naturals Cannabis Products Launch Nationwide In Canada
March 24, 2023
From Benzinga
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More
March 20, 2023
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Braxia Scientific's Q3 2023 Finances, Update On Upcoming Acquisition With Irwin Naturals
March 02, 2023
From Benzinga
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
February 27, 2023
From Benzinga
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
February 21, 2023
From Benzinga
Irwin Naturals Acquires Ketamine Clinic In Kentucky Adding $3M In Projected EBITDA
February 21, 2023
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.